You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 94 No. 3, SEPTEMBER 1954 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

TREATMENT OF ACUTE LEUKEMIA WITH CORTISONE AND CORTICOTROPIN

PHAEDON FESSAS, M.D.; M. M. WINTROBE, M.D.; R. B. THOMPSON, M.D.; G. E. CARTWRIGHT, M.D.

AMA Arch Intern Med. 1954;94(3):384-401.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ALTHOUGH the usefulness of the hormones corticotropin and cortisone in the treatment of acute leukemia has become quite clear, little consideration has been given to the possible reasons for the effectiveness of these agents in some cases and their failure in others. We have become impressed that in certain cases the course of the illness has even seemed to become accelerated in association with such hormone therapy. A review of our own experience was therefore initiated and the present report represents the results of that study.

REVIEW OF LITERATURE

A review of the literature reveals that others have made somewhat similar observations, although a critical analysis of experience in a single clinic has not been published. In Table 1 a summary is given of the recorded data. Unfortunately, a number of investigators have not attempted to differentiate the various types of acute leukemia. Others have done so, but criteria for . . . [Full Text PDF of this Article]


Author Affiliations

SALT LAKE CITY

From the Department of Medicine, College of Medicine, University of Utah.


Footnotes

This investigation was supported in part by a research grant, C-2349, from The National Cancer Institute, of the National Institutes of Health, Public Health Service.

Fellow of the Damon Runyon Memorial Fund for Cancer Research (Dr. Fessas) and Commonwealth Fund Fellow; present address, University of Durham Medical School, King's College, Newcastle-upon-Tyne, England (Dr. Thompson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1954 American Medical Association. All Rights Reserved.